Stock 1541 IMMUNEONCO BIOPHARMACEUTICALS (SHANGHAI) INC.
Add to a list
To use this feature you must be a member
Log inSign up

Press Releases ImmuneOnco Biopharmaceuticals (Shanghai) Inc.

Equities

1541

CNE100006624

Delayed Hong Kong S.E.
Other stock markets
 01:09:27 2024-07-18 am EDT 		5-day change 1st Jan Change
12.88 HKD +0.16% Intraday chart for ImmuneOnco Biopharmaceuticals (Shanghai) Inc. -0.77% -56.92%
Jul. 03 ImmuneOnco Doses First Patient in Phase 3 Clinical Trial of Hodgkin Lymphoma Drug MT
Jul. 03 ImmuneOnco Biopharmaceuticals Inc. Announces Updates on the Clinical Trial of IMM01 (Timdarpacept) in Combination with Tislelizumab CI

Press Releases

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. 1541 Stock
  4. News ImmuneOnco Biopharmaceuticals (Shanghai) Inc.
  5. Press Releases